Lack of effect of nitrogen dioxide exposure on heart rate variability in patients with stable coronary heart disease and impaired left ventricular systolic function

Alison Scaife, Justin Barclay, Graham S. Hillis, Janaki Srinivasin, David W. Macdonald, John Ross, Jon G. Ayres

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Objectives Epidemiological studies of air pollution on cardiovascular health show associations of cardiac mortality and admissions with exposure to nitrogen dioxide (NO2) at low concentrations. These associations could be causal or NO2 could be acting as a surrogate measure for another air pollutant, most likely ultrafine particles. No studies of cardiac susceptibility to acute exposure to NO2 have been undertaken.

Methods Randomised controlled exposures to NO2 (400 ppb for 1 h) and air in subjects with coronary heart disease and impaired left ventricular systolic function not taking ß adrenoceptor blocking drugs.

Results There were no significant changes in heart rate, blood pressure, leucocyte coping capacity or any heart rate variability measure following NO2 exposure compared with air.

Conclusion These findings suggest that NO2 does not affect heart rate variability at these concentrations (which are high for urban background levels) and in the absence of other pollutants. While a synergistic effect has not been ruled out, these data lend support to the idea that the epidemiological data associating cardiac outcomes with NO2 are more likely due to an associated pollutant rather than NO2 itself.
Original languageEnglish
Pages (from-to)587-591
Number of pages5
JournalOccupational and Environmental Medicine
Volume69
Issue number8
Early online date12 Jun 2012
DOIs
Publication statusPublished - Aug 2012

Keywords

  • nitrogen dioxide
  • air CO2 enrichment
  • coronary heart disease
  • heart rate variability

Fingerprint

Dive into the research topics of 'Lack of effect of nitrogen dioxide exposure on heart rate variability in patients with stable coronary heart disease and impaired left ventricular systolic function'. Together they form a unique fingerprint.

Cite this